Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT03987711

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03987711
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03987711. Randomized; no masking; primary purpose treatment. Start 2019-12-10 (actual); primary completion 2022-12-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
Acronym
SAFE-D
Condition
End Stage Renal Failure on Dialysis
Intervention (Drug)
Warfarin
Intervention (Drug)
Apixaban
Intervention (Other)
No oral anticoagulation
Lead sponsor
Unity Health Toronto (class: other)
Collaborator
Canadian Institutes of Health Research (CIHR) (class: other government)
Collaborator
The George Institute for Global Health (Sydney, Australia) (class: not stated)

Record details

Record id
cardio:ct-nct03987711
Content hash
af3975156b75c6b83983b5dd1edd280ce7884efb5d1bfe876e5e55e7928f9a8c